Is rivaroxaban a cost-effective anticoagulation therapy compared with warfarin?

Matthew Hawks, David Moss

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	14-15
Number of pages	2
Journal	Evidence-Based Practice
Volume	20
Issue number	10
DOIs	https://doi.org/10.1097/01.ebp.0000541851.44113.f8
State	Published - Oct 2017
Externally published	Yes

Access to Document

10.1097/01.ebp.0000541851.44113.f8

Cite this

@article{585c643294174590ad723e8b5723ec32,

title = "Is rivaroxaban a cost-effective anticoagulation therapy compared with warfarin?",

author = "Matthew Hawks and David Moss",

year = "2017",

month = oct,

doi = "10.1097/01.ebp.0000541851.44113.f8",

language = "English",

volume = "20",

pages = "14--15",

journal = "Evidence-Based Practice",

issn = "1095-4120",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - Is rivaroxaban a cost-effective anticoagulation therapy compared with warfarin?

AU - Hawks, Matthew

AU - Moss, David

PY - 2017/10

Y1 - 2017/10

UR - http://www.scopus.com/inward/record.url?scp=85050731114&partnerID=8YFLogxK

U2 - 10.1097/01.ebp.0000541851.44113.f8

DO - 10.1097/01.ebp.0000541851.44113.f8

M3 - Comment/debate

AN - SCOPUS:85050731114

SN - 1095-4120

VL - 20

SP - 14

EP - 15

JO - Evidence-Based Practice

JF - Evidence-Based Practice

IS - 10

ER -